HIV pre-exposure prophylaxis: assessment of acceptability among members of HIV serodiscordant/serostatus unknown couples. 2022

Edith Bracho-Sanchez, and Samantha Stonbraker, and Mina Halpern, and Sarah Wood, and Elizabeth Lowenthal
21611Columbia University Irving Medical Center, New York, NY, USA.

Pre-exposure prophylaxis (PrEP) is effective in preventing HIV infection but is not yet widely available in resource-limited settings such as the Dominican Republic. We aimed to ascertain PrEP acceptability among people living with HIV in the Dominican Republic who are part of HIV serodiscordant partnerships and understand relationships between PrEP acceptability, HIV stigma, and intimate partner violence.Methods: A cross-sectional survey of people in care for HIV infection included acceptability-related questions and assessments of HIV stigma and intimate partner violence. We also explored the expected impact of PrEP on HIV disclosure rates and fertility intentions.Results: Of the 100 participants, 74% had been in their current partnership for >1 year; 38% had not disclosed to their partner; 29% reported condomless sex, and 23% reported sex with multiple partners. PrEP was highly acceptable with 84% of participants saying they were "very likely" to offer PrEP to their partner if available and 21% stating it would allow them to have more children. Of those who had not disclosed to their partner, 71% stated PrEP would help them do so. No relationship was found between PrEP acceptability, HIV stigma, and intimate partner violence. However, higher than expected rates of PrEP acceptability limited the power of these analyses.Conclusion: Pre-exposure prophylaxis was considered to be highly acceptable among people living with HIV in the Dominican Republic who are part of serodiscordant partnerships.

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012747 Sexual Partners Married or single individuals who share sexual relations. Multiple Partners Sexual,Multiple Sex Partners,Multiple Sexual Partners,Sex Partners,Partner, Sex,Partner, Sexual,Sex Partner,Sex Partner, Multiple,Sex Partners, Multiple,Sexual Partner,Sexual Partner, Multiple
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D065129 Pre-Exposure Prophylaxis A method of disease prevention (abbreviated PrEP) which involves the administration of drugs to at-risk persons who have not been exposed to the disease-causing agent. Pre-Exposure Prophylaxis (PrEP),Pre Exposure Prophylaxis,Pre Exposure Prophylaxis (PrEP),Pre-Exposure Prophylaxi,Pre-Exposure Prophylaxi (PrEP),Prophylaxi, Pre-Exposure,Prophylaxi, Pre-Exposure (PrEP),Prophylaxis, Pre-Exposure,Prophylaxis, Pre-Exposure (PrEP)

Related Publications

Edith Bracho-Sanchez, and Samantha Stonbraker, and Mina Halpern, and Sarah Wood, and Elizabeth Lowenthal
January 2021, Global health action,
Edith Bracho-Sanchez, and Samantha Stonbraker, and Mina Halpern, and Sarah Wood, and Elizabeth Lowenthal
October 1998, AIDS care,
Edith Bracho-Sanchez, and Samantha Stonbraker, and Mina Halpern, and Sarah Wood, and Elizabeth Lowenthal
July 2020, AIDS patient care and STDs,
Edith Bracho-Sanchez, and Samantha Stonbraker, and Mina Halpern, and Sarah Wood, and Elizabeth Lowenthal
September 2014, AIDS and behavior,
Edith Bracho-Sanchez, and Samantha Stonbraker, and Mina Halpern, and Sarah Wood, and Elizabeth Lowenthal
August 2017, AIDS patient care and STDs,
Edith Bracho-Sanchez, and Samantha Stonbraker, and Mina Halpern, and Sarah Wood, and Elizabeth Lowenthal
January 2018, Journal of health disparities research and practice,
Edith Bracho-Sanchez, and Samantha Stonbraker, and Mina Halpern, and Sarah Wood, and Elizabeth Lowenthal
February 2018, Journal of acquired immune deficiency syndromes (1999),
Edith Bracho-Sanchez, and Samantha Stonbraker, and Mina Halpern, and Sarah Wood, and Elizabeth Lowenthal
January 2019, The Journal of the Association of Nurses in AIDS Care : JANAC,
Edith Bracho-Sanchez, and Samantha Stonbraker, and Mina Halpern, and Sarah Wood, and Elizabeth Lowenthal
August 2016, Sexually transmitted diseases,
Edith Bracho-Sanchez, and Samantha Stonbraker, and Mina Halpern, and Sarah Wood, and Elizabeth Lowenthal
January 2011, PloS one,
Copied contents to your clipboard!